New drug MER511 enters first human trial for Graves' disease
NCT ID NCT07305818
First seen Jan 04, 2026 · Last updated May 22, 2026 · Updated 26 times
Summary
This early-stage study tests a new drug called MER511 in 100 adults with Graves' disease, a condition where the immune system attacks the thyroid. The goal is to see if the drug is safe and how the body handles it. Participants will receive the drug either through a vein or under the skin, and will be closely monitored for side effects and changes in blood tests.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GRAVES DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Site # 1101
RECRUITINGHollywood, Florida, 33024, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Site # 1102
RECRUITINGRochester, Minnesota, 55905, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Site # 1103
RECRUITINGPhoenix, Arizona, 85053, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Site # 1104
RECRUITINGColumbus, Ohio, 43203, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Site # 1105
RECRUITINGWebster, Texas, 77598, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Site # 1107
RECRUITINGBoston, Massachusetts, 02114, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Site # 1108
RECRUITINGPhiladelphia, Pennsylvania, 19107, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.